Bone Effect of Low Dose Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma

Yogesh Jethava¹, Karen Pena², Donghoon Yoon¹, Caleb Stein¹ and Maurizio Zangari^1*

¹University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy, Little Rock, AR, USA

²Huntman Cancer Institute, Department of Clinical Trials, Salt Lake City, UT, USA

^*Corresponding Author: Maurizio Zangari, University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy, Little Rock, AR, USA, Tel: 5016868230 Email: